Collaborations & Alliances

Takeda Selects leon-nanodrugs’s MicroJet Reactor for Feasibility

Assessment could potentially lead to the development of an innovative formulation of one of Takeda's pipeline products

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Takeda Pharmaceutical Co. Ltd. has selected leon-nanodrugs GmbH’s MicroJet Reactor for a feasibility assessment that could potentially lead to the development of an innovative formulation of one of their current pipeline products.   Under the companies’ collaboration, leon will support Takeda`s formulation efforts to optimize solubility, bioavailability and stability for one of Takeda’s current pipeline products for drug delivery using leon’s nanotechnology platform – MicroJet Reactor. The pla...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters